Home › Appendiceal Cancer
Appendiceal Cancer clinical trials recruiting in the U.S.
17 studies for Appendiceal Cancer are recruiting participants at sites across the United States.
Cities with the most studies
By state
- California9 studies
- Florida3 studies
- Maryland3 studies
- Michigan3 studies
- New York4 studies
- Pennsylvania4 studies
- Tennessee4 studies
- Virginia3 studies
Recently updated studies
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Nov 12, 2026 · NCT04847063Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Recruiting
Ages 18 to 99 · All sexes · Updated Nov 12, 2026 · NCT04907643A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07020221Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07271355Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07283939Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07124351Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07487168EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Recruiting
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06263088PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT04329494The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT07769346A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis
Recruiting
Ages 18 to 81 · All sexes · Updated Jul 21, 2026 · NCT07291180Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
Recruiting
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT06101277Molecular Profiling for Risk Stratification in Appendiceal Cancer
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT07587268Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
Recruiting
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT05780684Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 1, 2026 · NCT04779554Genetics of Appendix Cancer Study
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 18, 2025 · NCT05734430From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.